A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases

The anticancer action and PK profile of Cellax (a nanoparticle formulation of docetaxel), were contrasted with Abraxane, an approved nanoparticle formulation of paclitaxel. Cellax exhibited particular advantages against metastatic breast cancer.80